Modifying risks of secondary leukemias: Is drug scheduling important?

J. E. Karp, M. A. Smith

Research output: Contribution to journal › Editorial › peer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Modifying risks of secondary leukemias: Is drug scheduling important?'. Together they form a unique fingerprint.